Intellectual Property Law

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization
Dec
14
2023
USPTO to Open Regional Office in Atlanta Womble Bond Dickinson (US) LLP
Dec
14
2023
Second Circuit Hands Vans a Win in First Appellate Decision to Apply Jack Daniel’s Greenberg Traurig, LLP
Dec
13
2023
Supercapacitor Patent Row Between CAP-XX and Maxwell Technologies Goes to Court this Week Mintz
Dec
13
2023
Aussie Burger Wars Continue: KFC v HFC K&L Gates
Dec
13
2023
Federal Circuit Evaluates Impact of the Final Written Decision (FWD) in a Parallel Inter-Partes Review (IPR) on District Court’s decision of Invalidity and Infringement Sheppard, Mullin, Richter & Hampton LLP
Dec
13
2023
Influence At Your Own Risk: Navigating Influencer Contracts ArentFox Schiff LLP
Dec
13
2023
A Proposed Likeness Law Paves the Way for a New Federal Right of Action Squire Patton Boggs (US) LLP
Dec
12
2023
Copyright Office Review Board Denies AI-Human Authorship Claim for Third Time ArentFox Schiff LLP
Dec
12
2023
How Artificial Intelligence is Changing the Game of Professional Sports Squire Patton Boggs (US) LLP
Dec
11
2023
Startup Advisors: What Sources of Financing are Available to Startups? [VIDEO] Foley & Lardner LLP
Dec
11
2023
The March on Pharmaceutical Patents? Sheppard, Mullin, Richter & Hampton LLP
Dec
11
2023
Deadline Dexterity: PTAB Has Authority to Issue Decisions After Statutory Deadline Proskauer Rose LLP
Dec
10
2023
Second Circuit Finds Art Collective Can’t Use First Amendment to Skate Out of Injunction Sheppard, Mullin, Richter & Hampton LLP
Dec
10
2023
Will Supreme Court Consider Whether to Allow an Alternative to In-App Purchasing on the App Store? Sheppard, Mullin, Richter & Hampton LLP
Dec
10
2023
Federal Circuit Vacates PTAB’s Decision Based on an Overly Narrow Claim Construction Sheppard, Mullin, Richter & Hampton LLP
Dec
10
2023
China Releases Second Batch of Warning Cases in ‘Blue Sky’ Special Rectification Program of the Patent Agent Industry Schwegman, Lundberg & Woessner, P.A.
Dec
10
2023
Federal Circuit’s Determination on Whether Fraudulent Conduct in Obtaining Incontestable Status Warrants the Mark’s Cancellation Sheppard, Mullin, Richter & Hampton LLP
Dec
10
2023
Cyntec Company, Ltd. v. Chilisin Electronics Corp., Chilisin America Ltd. Nos. 2022-1873, (Fed. Cir. October 16, 2023) Sheppard, Mullin, Richter & Hampton LLP
Dec
10
2023
Axonics, Inc. v. Medtronic, Inc. Nos. 2022-1532, 2022-1533, (Fed. Cir. August 7, 2023) Sheppard, Mullin, Richter & Hampton LLP
Dec
9
2023
Unpredictability In The Art: Amgen v. Sanofi In View Of “Simultaneous Conception And Reduction To Practice” Womble Bond Dickinson (US) LLP
Dec
7
2023
The Art of Teaching Complex Technology in Patent Litigation – Episode 67 [Podcast] IMS Legal Strategies
Dec
7
2023
Question of the Week: What Do You Expect the Biggest Impacts of Generative AI (GenAI) to be on M&A in the Next 12-18 Months? Proskauer Rose LLP
Dec
7
2023
USPTO Launches Semiconductor Technology Pilot Program to Expedite Patent Examinations and Support the CHIPS Act Womble Bond Dickinson (US) LLP
Dec
7
2023
Getty Image’s AI Model Training Lawsuit in UK Against Stability to Proceed Sheppard, Mullin, Richter & Hampton LLP
Dec
7
2023
PTO Creates Separate Design Patent Bar McDermott Will & Emery
Dec
7
2023
Word From on High: Provide Reasoned Explanation When Departing From Established Practice McDermott Will & Emery
Dec
6
2023
Basics – How an Inventor’s Own Work Affects Patent Applications Mintz
Dec
6
2023
Changing of the Guard: NCAA Presents Pathway for Division I Schools to Pay Athletes Jackson Lewis P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins